文献速递基础与转化研究流行病学与生物统计组学、生物样本库与精准医学

臀股与腹部脂肪分布的遗传变异与2型糖尿病、冠心病及心血管危险因素的关联

Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
PubMed 文献 · JAMA · 2018-01-01

本研究利用全基因组关联分析识别通过降低臀股脂肪或增加腹部脂肪特异性升高腰臀比的遗传变异,并构建多基因评分,在多个队列中评估其与心血管代谢风险的关联。结果显示两种评分均与血压、甘油三酯升高及糖尿病和冠心病风险增加相关,提示不同脂肪分布机制影响心血管代谢风险。

要点

  • 腰臀比相关遗传变异可区分臀股型与腹部型脂肪分布。
  • 两种脂肪分布多基因评分均与糖尿病和冠心病风险升高相关。
  • 臀股型评分与糖尿病关联的效应量大于腹部型评分。

核心结论

  • 通过降低臀股脂肪或增加腹部脂肪升高腰臀比的遗传机制不同,但均与糖尿病和冠心病风险增加相关。

研究设计与样本

  • 全基因组关联分析整合UK Biobank队列与既往GWAS汇总数据,数据收集于2006-2018年。
  • 在3个人群队列、1个病例队列研究及6个GWAS汇总数据中评估多基因评分与结局的关联,数据收集于1991-2018年。

主要发现

  • 每增加1个SD的BMI校正腰臀比,腹部特异性评分与冠心病风险相关(OR 1.60,95%CI 1.39-1.84;每1000人年绝对风险增加2.3,95%CI 1.5-3.3;P<.001),臀股特异性评分与冠心病风险相关(OR 1.76,95%CI 1.53-2.02;每1000人年绝对风险增加3.0,95%CI 2.1-4.0;P<.001)。

临床怎么用

  • 腰臀比升高背后的不同脂肪分布遗传机制可能有助于改善糖尿病和冠心病的风险评估与治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Body fat distribution, usually measured using waist-to-hip ratio (WHR), is an important contributor to cardiometabolic disease independent of body mass index (BMI). Whether mechanisms that increase WHR via lower gluteofemoral (hip) or via higher abdominal (waist) fat distribution affect cardiometabolic risk is unknown. OBJECTIVE: To identify genetic variants associated with higher WHR specifically via lower gluteofemoral or higher abdominal fat distribution and estimate their association with cardiometabolic risk. DESIGN, SETTING, AND PARTICIPANTS: Genome-wide association studies (GWAS) for WHR combined data from the UK Biobank cohort and summary statistics from previous GWAS (data collection: 2006-2018). Specific polygenic scores for higher WHR via lower gluteofemoral or via higher abdominal fat distribution were derived using WHR-associated genetic variants showing specific association with hip or waist circumference. Associations of polygenic scores with outcomes were estimated in 3 population-based cohorts, a case-cohort study, and summary statistics from 6 GWAS (data collection: 1991-2018). EXPOSURES: More than 2.4 million common genetic variants (GWAS); polygenic scores for higher WHR (follow-up analyses). MAIN OUTCOMES AND MEASURES: BMI-adjusted WHR and unadjusted WHR (GWAS); compartmental fat mass measured by dual-energy x-ray absorptiometry, systolic and diastolic blood pressure, low-density lipoprotein cholesterol, triglycerides, fasting glucose, fasting insulin, type 2 diabetes, and coronary disease risk (follow-up analyses). RESULTS: Among 452 302 UK Biobank participants of European ancestry, the mean (SD) age was 57 (8) years and the mean (SD) WHR was 0.87 (0.09). In genome-wide analyses, 202 independent genetic variants were associated with higher BMI-adjusted WHR (n = 660 648) and unadjusted WHR (n = 663 598). In dual-energy x-ray absorptiometry analyses (n = 18 330), the hip- and waist-specific polygenic scores for higher WHR were specifically associated with lower gluteofemoral and higher abdominal fat, respectively. In follow-up analyses (n = 636 607), both polygenic scores were associated with higher blood pressure and triglyceride levels and higher risk of diabetes (waist-specific score: odds ratio [OR], 1.57 [95% CI, 1.34-1.83], absolute risk increase per 1000 participant-years [ARI], 4.4 [95% CI, 2.7-6.5], P < .001; hip-specific score: OR, 2.54 [95% CI, 2.17-2.96], ARI, 12.0 [95% CI, 9.1-15.3], P < .001) and coronary disease (waist-specific score: OR, 1.60 [95% CI, 1.39-1.84], ARI, 2.3 [95% CI, 1.5-3.3], P < .001; hip-specific score: OR, 1.76 [95% CI, 1.53-2.02], ARI, 3.0 [95% CI, 2.1-4.0], P < .001), per 1-SD increase in BMI-adjusted WHR. CONCLUSIONS AND RELEVANCE: Distinct genetic mechanisms may be linked to gluteofemoral and abdominal fat distribution that are the basis for the calculation of the WHR. These findings may improve risk assessment and treatment of diabetes and coronary disease.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Lotta LA, Wittemans LBL, Zuber V, et al. Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors. JAMA. 2018. PMID: 30575882. doi:10.1001/jama.2018.19329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。